Lexinova Bioscience Corp Lexington, MA - 02420

Lexinova Bioscience Corp is categorized under Research and Development Laboratories in Lexington, MA and active since 2009.

Lexinova Bioscience Corp was established in 2009, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact Zhiqiang Han at the company’s single location by writing to 46 Ledgelawn Avenue, Lexington, Massachusetts MA 02420 or by phoning (781) 698-6587. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Lexinova Bioscience Corp
Contact Person: Zhiqiang Han
Address: 46 Ledgelawn Avenue, Lexington, Massachusetts 02420
Phone Number: (781) 698-6587
Annual Revenue (USD): $50.000 to $99.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research and Development Laboratories
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Lexinova Bioscience Corp was started in 2009 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact Zhiqiang Han for inquiries that concern Lexinova Bioscience Corp by calling the company number (781) 698-6587, as your correspondence is most welcome. Additionally, the physical location of the single location of Lexinova Bioscience Corp can be found at the coordinates 42.461739,-71.233935 as well as the street address 46 Ledgelawn Avenue in Lexington, Massachusetts 02420.

For its online presence, you may visit Lexinova Bioscience Corp’s website at and engage with its social media outlets through on Twitter and on Facebook.